Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Misses On Secondary Endpoint
FDA Approves First Nasal Spray For Dry Eye Disease From Oyster Point Pharma
Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial
Oyster Point Inks License Pact With Ji Xing Pharma For Dry Eye Disease Candidates In Greater China
Dry Eye Disease Recent News
Palatin Technologies Stock Moves Higher After Outlining Plans For Dry Eye Disease Treatment
FDA Accepts Oyster Point's Varenicline Nasal Spray Application For Review In Dry Eye Disease
Ocular Therapeutix Shares Are Trading Higher As Company Starts Dosing In Mid-Stage Therapy Study For Dry Eye Disease
Palatin Shares Spikes On International Patent Application Covering Its Dry Eye Disease Candidate
Eyegate Pharmaceuticals Receives FDA Approval To Begin PE Pilot Study
Aurinia's Dry Eye Syndrome Drug Produces Mixed Results In Mid-Stage Trial
Aldeyra's Dry Eye Disease Aces Mid-Stage Trial, Stock Soars
Imprimis Launches 99-Cent Generic Drug To Compete With Allergan's Restasis